Neue Aspekte in der Therapie von Vorhofflimmern

Schlüsselwörter

Vorhofflimmern - medikamentöse Therapie - Antikoagulation - Ablation

Keywords

atrial fibrillation - drug therapy - anticoagulation - ablation

Literatur

• 1 Boersma L, Wijffels M C, Oral H, Wever E F, Morady F. Pulmonary vein isolation by duty-cycled bipolar and unipolar radiofrequency energy with a multielectrode ablation catheter.  Heart Rhythm. 2008;  5 1635-1642
• 2 Bittner A, Mönnig G, Zellerhoff S. et al . Randomized study comparing duty-cycled bipolar and unipolar radiofrequency with point-by-point ablation in pulmonary vein isolation.  Heart Rhythm. 2011, im Druck; 
• 3 Calkins H, Reynolds M R, Spector P. et al . Treatment of atrial fibrillation with antiarrhythmic drugs or radiofrequency ablation.  Circ Arrhythm Electrophysiol. 2009;  2 349-361
• 4 Camm A J, Capucci A, Hohnloser S H. et al . A randomized active-controlled study comparing the efficacy and saftey of vernakalant to amiodaron in recent-onset atrial fibrillation.  J Am Coll Cardiol. 2011;  57 313-32
• 5 Connolly S J, Ezekowitz M D, Yusuf S. et al . Dabigatran versus warfarin in patients with atrial fibrillation.  N Engl J Med. 2009;  361 1139-1151
• 6 Connolly S J, Crijns H J, Torp-Pedersen C. et al . Analysis of stroke in ATHENA: a placebo-controlled, double-blind, parallel-arm trial to assess the efficacy of dronedaron 400 mg BID for the prevention of cardiovascular hospitalization or death from any cause in patients with atrial fibrillation/atrial flutter.  Circulation. 2009;  120 1174-1180
• 7 Corley S D, Epstein A E. et al . Relationships between sinus rhythm, treatment, and survival in the Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) Study.  Circulation. 2004;  109 1509-1513
• 8 Deneke T, de Groot J R, Horlitz M. et al . Pulmonary vein isolation using a novel decapolar over-the-wire mapping and ablation catheter.  Expert Rev Cardiovasc Ther. 2009;  7 1341-1347
• 9 Diener H C, Connolly S J, Ezekowitz M D. et al . Dabigatran compared with warfarin in patients with atrial fibrillation and previous transient ischaemic attack or stroke: a subgroup analysis of the RE-LY trial.  Lancet Neurol. 2010;  9 1157-1163
• 10 Dukkipati S R, Neuzil P, Skoda J. et al . Visual balloon-guided point-by-point ablation: reliable, reproducible, and persistent pulmonary vein isolation.  Circ Arrhythm Electrophysiol. 2010;  3 266-273
• 11 Guidelines for the management of atrial fibrillation. The tasc force for the management of atrial fibrillation of the European Society of Cardiology.  Eur Heart J. 2010;  31 2369-2429
• 12 Hagens V E, Crijns H J. et al . Rate control versus rhythm control for patients with persistent atrial fibrillation with mild to moderate heart failure: results from the Rate Control versus Electrical cardioversion (RACE) study.  Am Heart J. 2005;  149 1106-1111
• 13 Hohnloser S H, Crijns H J. et al . Effect of dronedaron on cardiovascular events in atrial fibrillation.  N Engl J Med. 2009;  360 668-678
• 14 Holmes D R, Reddy V Y, Turi Z G. et al . Percutanous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation.  Lancet. 2009;  374 534-542
• 15 Jais P, Cauchemez B, Macle L. et al . Catheter ablation versus antiarrhythmic drugs for atrial fibrillation: the A4 study.  Circulation. 2008;  118 2498-2505
• 16 Le Heuzey J Y, De Ferrari G M, Radzik D, Santini M, Zhu J, Davy J M. A short-term, randomized, double-blind, parallel-group study to evaluate the efficacy and safety of dronedaron versus amiodaron in patients with persistent atrial fibrillation: the DIONYSOS study.  J Cardiovasc Electrophysiol. 2010;  21 597-605
• 17 Neumann T, Vogt J, Schumacher B. et al . Circumferential pulmonary vein isolation with the cryoballoon technique results from a prospective 3-center study.  J Am Coll Cardiol. 2008;  52 273-278
• 18 Orlov M V, Gardin J M, Slawsky M. et al . Biventricular pacing improves cardiac function and prevents further left atrial remodeling in patients with symptomatic atrial fibrillation after atrioventricular node ablation.  Am Heart J. 2010;  159 264-270
• 19 Ouyang F, Tilz R, Chun J. et al . Long-term results of catheter ablation in paroxysmal atrial fibrillation.  Circulation. 2010;  122 2368-2377
• 20 Tanner H, Makowski K, Roten L. et al . Catheter ablation of atrial fibrillation as first-line therapy.  Europace. 2011;  13 646-653
• 21 Van Gelder I C, Groenveld H F, Crijns H J. et al . Lenient versus strict rate control in patients with atrial fibrillation.  N Engl J Med. 2010;  362 1363-1373
• 22 Wasmer K, Eckardt L. Management of atrial fibrillation around the world: a comparison of current ACCF/AHA/HRS, CCS, and ESC guidelines.  Europace. 2011, epub ahead of print; 
• 23 Weerasooriya R, Khairy P, Litalien J. et al . Catheter ablation for atrial fibrillation: results maintained at 5 years of follow-up?.  J Am Coll Cardiol. 2011;  57 160-166
• 24 Wilber D J, Pappone C, Neuzil P. et al . Comparison of antiarrhythmic drug therapy and radiofrequency catheter ablation in patients with paroxysmal atrial fibrillation.  JAMA. 2010;  303 333-340